GlycoMimetics reports data from Phase III AML treatment trial Clinical Trials Arena - 07 May 2024 GlycoMimetics reports data from Phase III AML treatment trial ... More
Uproleselan Plus Chemotherapy Misses OS End Point in R/R AML OncLive - 06 May 2024 Uproleselan Plus Chemotherapy Misses OS End Point in R/R AML ... More
Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim ... PR Newswire - 07 May 2024 Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim ... ... More
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow ... Nature.com - 07 May 2024 Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow ... ... More
New CAR T Cell Clinical Trial for Acute Myeloid Leukemia Is First of Its Kind - On Cancer Memorial Sloan Kettering - 22 Apr 2024 New CAR T Cell Clinical Trial for Acute Myeloid Leukemia Is First of Its Kind ... More
Glycomimetics wilts on missed acute myeloid leukemia phase III BioWorld Online - 06 May 2024 Glycomimetics wilts on missed acute myeloid leukemia phase III ... More
GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute ... Business Wire - 06 May 2024 GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute ... ... More
World Acute Myeloid Leukemia Day: Advancing research to serve patients Servier - 21 Apr 2024 World Acute Myeloid Leukemia Day: Advancing research to serve patients ... More
Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines UCHealth Today - 22 Apr 2024 Promising acute myeloid leukemia treatment helps put Matt Lubick back on the sidelines ... More
GlycoMimetics fails phase 3 blood cancer trial, causing investors to sour on stock Fierce Biotech - 06 May 2024 GlycoMimetics fails phase 3 blood cancer trial, causing investors to sour on stock ... More
Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence | npj ... Nature.com - 20 Mar 2024 Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence | npj ... ... More
Earlier CAR T Use in Multiple Myeloma: Game Changer or Boutique Medicine? OncLive - 07 May 2024 Earlier CAR T Use in Multiple Myeloma: Game Changer or Boutique Medicine? ... More
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic ... Nature.com - 28 Feb 2024 Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic ... ... More
Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and ... Nature.com - 01 Mar 2024 Designing patient-oriented combination therapies for acute myeloid leukemia based on efficacy/toxicity integration and ... ... More
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody | Blood Cancer ... Nature.com - 18 Apr 2024 Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody | Blood Cancer ... ... More
A new genomic framework to categorize pediatric acute myeloid leukemia Nature.com - 11 Jan 2024 A new genomic framework to categorize pediatric acute myeloid leukemia ... More
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century | Blood Cancer Journal Nature.com - 14 Mar 2024 Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century | Blood Cancer Journal ... More
Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus ... Nature.com - 26 Mar 2024 Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus ... ... More
Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic ... Nature.com - 11 Mar 2024 Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic ... ... More